What Do We Know about Medication Adherence Interventions in Inflammatory Bowel Disease, Multiple Sclerosis and Rheumatoid Arthritis? A Scoping Review of Randomised Controlled Trials
Kathryn King,1 Serena McGuinness,1 Natalie Watson,1 Christine Norton,1 Trudie Chalder,2 Wladyslawa Czuber-Dochan1 1Florence Nightingale Faculty Nursing, Midwifery and Palliative Care, King’s College London, London, UK; 2Department of Psychological Medicine, Institute of Psychiatry, Psychology and Ne...
Main Authors: | King K, McGuinness S, Watson N, Norton C, Chalder T, Czuber-Dochan W |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-12-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/what-do-we-know-about-medication-adherence-interventions-in-inflammato-peer-reviewed-fulltext-article-PPA |
Similar Items
-
The Prevalence of extraintestinal manifestations in Inflammatory Bowel Disease
by: Aleksandra Madej, et al.
Published: (2024-02-01) -
Adherence to Recommended Immunization Schedules in Patients with Inflammatory Bowel Disease on Biologics and Small Molecule Therapies
by: Mohammad Shehab, et al.
Published: (2023-09-01) -
Low Vitamin K and Vitamin D Dietary Intake in Patients with Inflammatory Bowel Diseases
by: Filippo Vernia, et al.
Published: (2023-03-01) -
Psoriasis/Psoriatic Arthritis Patients’ Long-term Treatment Patterns and Adherence to Systemic Treatments Monitoring Recommendations
by: Åsa Krantz, et al.
Published: (2023-06-01) -
Infertility in patients with Inflammatory Bowel Disease (IBD): a challenge to overcome
by: Arkadiusz Aab, et al.
Published: (2023-05-01)